Safety Profile of Medicines Used for the Treatment of Drug-Resistant Tuberculosis: A Descriptive Study Based on the WHO Database (VigiBase ® ).

Alemayehu Lelisa Duga Francesco Salvo Alexander W Kay Albert Figueras

Published in: Antibiotics (Basel, Switzerland) (2023)

A third of the reports required medication withdrawal, which impacts treatment adherence and ultimately leads to drug resistance. Additionally, more than 40% of the reports indicated that ADRs appeared two months after the commencement of treatment, thus it's important to remain alert for the potential ADRs for the entire duration of the treatment.

Keyphrases

drug resistant
multidrug resistant
emergency department
adipose tissue
adverse drug
type diabetes
healthcare
risk assessment
acinetobacter baumannii
insulin resistance
skeletal muscle
pseudomonas aeruginosa
weight loss
human immunodeficiency virus
hiv aids